Valdecoxib

Get a Price/Quote

MOQ : 1 , , Kilograms

Valdecoxib Specification

Melting Point
(C), 157-159

Appearance
white crystalline powder

Molecular Weight
314.4 Grams (g)

Molecular Formula
‎C16H14N2O3S

Usage
Valdecoxib is a preferential cyclooxygenase-2 (COX-2) inhibitor belonging to the nonsteroidal anti-inflammatory drug (NSAID) class named Coxibs, used in the treatment of inflammatory diseases such as rheumatoid arthritis, osteoarthritis, dysmenorrheal, and as an adjuvant in some chronic and oncological diseases.

Valdecoxib Trade Information

Minimum Order Quantity
1 , , Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Kilograms Per Month

Delivery Time
3-4 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Main Export Market(s)
Western Europe, Australia, Middle East, Central America, South America, Asia, Eastern Europe, North America, Africa

Main Domestic Market
All India

About Valdecoxib

Valdecoxib is a white crystalline powder with a molecular weight of 314.4 grams and a molecular formula of C16H14N2O3S. Known for its preferential cyclooxygenase-2 (COX-2) inhibition, it belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs) named Coxibs. This compound is widely used in the treatment of inflammatory disorders such as rheumatoid arthritis, osteoarthritis, and dysmenorrhea. Valdecoxib also serves as an adjuvant therapy for certain chronic and oncological conditions. Featuring a melting point of 157-159C, this pharmaceutical-grade product provides consistent efficacy in managing pain and inflammation associated with a range of diseases. Due to its advanced pharmacological properties, Valdecoxib is a valuable solution for healthcare applications requiring targeted COX-2 inhibition. ---

FAQs of Valdecoxib:

Q: What is the primary use of Valdecoxib?

A: Valdecoxib is primarily used for the treatment of inflammatory conditions like rheumatoid arthritis, osteoarthritis, dysmenorrhea, and as an adjuvant in some chronic and oncological diseases.